WeVote

Bill

Bill

SB 282

Compounding drugs; registration of medical spas.

2026 Regular Session Introduced by Brad Barrett and 5 co-sponsors

Indiana SB 282 establishes registration requirements and regulatory oversight for medical spas and drug compounding facilities, requiring compliance with pharmacy and medical licensing standards.

Signed by the Governor
0
WeVote Research Nonpartisan
Bill Summary · SB 282

Legislative bill overview

SB 282 establishes a registration and regulatory framework for medical spas in Indiana while addressing the compounding of drugs used in these facilities. The bill passed the Senate with overwhelming support (43-6) and received House amendments before final Senate concurrence, indicating compromise was reached between chambers.

Why is this important

Medical spas operate in a regulatory gray area, offering cosmetic and wellness procedures that may use compounded pharmaceuticals. This legislation clarifies oversight requirements, which affects patient safety standards, business operations for medical spa owners, and the compounding pharmacy industry's scope of practice in Indiana.

Potential points of contention

  • Scope of "medical spa" definition: Disagreement may exist over which facilities must register and what procedures qualify, potentially creating competitive advantages or disadvantages for different business models
  • Compounding pharmacy oversight: The intersection of pharmacy regulation and medical spa operations could create friction between pharmacy boards and medical licensing boards regarding who has authority
  • Regulatory burden vs. consumer protection: Businesses may view registration requirements as costly compliance, while patient advocates may argue protections don't go far enough to prevent unsafe practices

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.